Compare Global X CleanTech (CTEC) vs Enveric Biosciences Inc (ENVB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Global X CleanTech vs Enveric Biosciences Inc — how do they compare? Global X CleanTech trades at $55.45 (market cap $24.57M), while Enveric Biosciences Inc trades at $1.51 (market cap $6.80M). The key difference: Global X CleanTech is far larger — about 3.6× Enveric Biosciences Inc's market cap, and Global X CleanTech is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Global X CleanTech for 42 Days and Enveric Biosciences Inc for 14 Days on average.
| CTEC | ENVB | |
|---|---|---|
Market Cap | $24.57M | $6.80M |
Volume | 1,220 | 64,867 |
Sector | Sector/Thematic | Health |
52-Week High | $78.11 | $10.80 |
52-Week Low | $50.82 | $1.27 |
Typical Hold Time | 42 Days | 14 Days |
Enterprise Value | — | -$1.49M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
ENVB trades at $1.495 with a 1.7% daily gain, showing technical bearish signals despite recent earnings beats. The company reported no revenue in 2025 with significant losses (-$8.77M net income), though valuation metrics appear low (EV/EBITDA 0.17, P/B 0.84). Recent news highlights patent approvals and positive preclinical data for non-hallucinogenic therapeutics.
The outlook remains speculative given the lack of revenue and substantial losses, offset by strong analyst support (75% buy rating) and promising drug development progress. Key risks include funding needs and clinical trial outcomes, while institutional sentiment appears cautiously optimistic about long-term pipeline potential.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Global X CleanTech
CTEC invests in companies at the forefront of the clean technology industry. It focuses on disruptive innovations in renewable energy production, energy storage, smart grids, and energy efficiency, with top holdings like Enphase and First Solar.
Read more on CTEC →About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →
